Patent · US Active

Marine actinomycete taxon for drug and fermentation product discovery

US7928138B2 · kind B2 · utility

14Cited by

37References

4Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Robert H. R. Feling · Wiesbaden, DE
William Fenical · Del Mar, US
Paul Jensen · San Diego, US
Tracy Mincer · San Diego, US

Key dates

Filing date	Dec 28, 2007
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Mar 27, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/36
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention is the discovery of an actinomycete genus, given the name Salinospora gen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature nucleotides. The invention is also the use of the genus for the production and discovery of active biomolecules such as pharmaceutical agents, agrichemicals, immunomodifiers, enzymes and enzyme inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.